These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23182787)

  • 1. [Early detection of ovarian cancer: tomorrow? A review].
    Chene G; Penault-Llorca F; Robin N; Cayre A; Provencher DM; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 2013 Feb; 42(1):5-11. PubMed ID: 23182787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is it possible to have organized screening for ovarian cancer?].
    Navone R; Montanari G
    Pathologica; 2003 Apr; 95(2):67-70. PubMed ID: 12768874
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preinvasive lesions in gynaecology -  ovary].
    Feranec R; Mouková L
    Klin Onkol; 2013; 26 Suppl():S54-5. PubMed ID: 24325167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection tools for pancreatic cancer.
    Schmidt C
    J Natl Cancer Inst; 2012 Aug; 104(15):1117-8. PubMed ID: 22851273
    [No Abstract]   [Full Text] [Related]  

  • 5. Early Events in the Molecular Pathogenesis of Lung Cancer.
    Kadara H; Scheet P; Wistuba II; Spira AE
    Cancer Prev Res (Phila); 2016 Jul; 9(7):518-27. PubMed ID: 27006378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP).
    Fishman DA; Bozorgi K
    Cancer Treat Res; 2002; 107():3-28. PubMed ID: 11775458
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transvaginal ultrasonography as a screening method for ovarian carcinoma].
    Ruseva R
    Akush Ginekol (Sofiia); 2000; 40(4):37-9. PubMed ID: 11288632
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
    Haugk B
    Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preinvasive lesions of the bronchus.
    Rivera MP
    Clin Chest Med; 2011 Dec; 32(4):693-702. PubMed ID: 22054880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
    Nossov V; Amneus M; Su F; Lang J; Janco JM; Reddy ST; Farias-Eisner R
    Am J Obstet Gynecol; 2008 Sep; 199(3):215-23. PubMed ID: 18468571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery in ovarian cancer.
    Tung CS; Wong KK; Mok SC
    Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening of ovarian cancer : not for tomorrow].
    Vuilleumier A; Labidi-Galy I
    Rev Med Suisse; 2017 May; 13(563):1039-1041. PubMed ID: 28636295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and monitoring of ovarian cancer.
    Su Z; Graybill WS; Zhu Y
    Clin Chim Acta; 2013 Jan; 415():341-5. PubMed ID: 23165217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary carcinoma and precancerous lesions of the vagina--the diagnostic difficulties].
    Veselinova T; Ivanova R; Marinov E; Gorchev G; Tsvetkov Ch
    Akush Ginekol (Sofiia); 1999; 38(3):38-40. PubMed ID: 10734680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
    Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
    Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling in ovarian cancer.
    Kim G; Minig L; Kohn EC
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2(Suppl 2):S2-6. PubMed ID: 19955909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human in vitro system for the detection of uterine cervical preinvasive carcinoma.
    Chaudhuri S; Koprowska I; Putong PB; Townsend DE
    Cancer Res; 1974 Jun; 34(6):1335-43. PubMed ID: 4826504
    [No Abstract]   [Full Text] [Related]  

  • 19. Early events in ovarian oncogenesis.
    Cvetkovic D
    Reprod Biol Endocrinol; 2003 Oct; 1():68. PubMed ID: 14577833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
    Spacek J; Jílek P; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.